Page last updated: 2024-08-23

pimonidazole and idoxuridine

pimonidazole has been researched along with idoxuridine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balm, A; Begg, AC; Blommestijn, G; Delaere, P; Hofland, I; Janssen, H; Raleigh, JA; Sciot, R; Sprong, D; Van Velthuyzen, L; Varia, M1
Balm, AJ; Begg, AC; Blijweert, E; Blommestijn, G; Delaere, P; Haustermans, KM; Hoebers, FJ; Hofland, I; Janssen, HL; Raleigh, JA; Sciot, R; Semenza, GL; Sprong, D; van Velthuysen, ML; Varia, MA1
Heerschap, A; Kaanders, JH; Lok, J; Peeters, WJ; Punt, CJ; Rijken, PF; Ruers, TJ; van der Kogel, AJ; van Laarhoven, HW; Wiering, B1
Begg, AC; De Schutter, H; Debucquoy, A; Ectors, N; Geboes, K; Goethals, L; Haustermans, KM; McBride, WH; Penninckx, F; Perneel, C1
Kaanders, JH; Marres, HA; Peters, JP; Rijken, PF; van der Kogel, AJ; Wijffels, KI1

Trials

1 trial(s) available for pimonidazole and idoxuridine

ArticleYear
Hypoxia and perfusion measurements in human tumors--initial experience with pimonidazole and IUdR.
    Acta oncologica (Stockholm, Sweden), 2001, Volume: 40, Issue:8

    Topics: Antibodies; Biopsy; Diffusion; Esophageal Neoplasms; Female; Head and Neck Neoplasms; Humans; Hypoxia; Idoxuridine; Kinetics; Male; Nitroimidazoles; Nucleic Acid Synthesis Inhibitors; Radiation-Sensitizing Agents; Rectal Neoplasms; Regional Blood Flow; Specimen Handling; Uterine Cervical Neoplasms

2001

Other Studies

4 other study(ies) available for pimonidazole and idoxuridine

ArticleYear
HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors.
    International journal of radiation oncology, biology, physics, 2002, Dec-01, Volume: 54, Issue:5

    Topics: Carcinoma, Squamous Cell; Dimerization; Dose-Response Relationship, Drug; Head and Neck Neoplasms; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Idoxuridine; Immunohistochemistry; Ki-67 Antigen; Neovascularization, Pathologic; Nitroimidazoles; Nucleic Acid Synthesis Inhibitors; Perfusion; Transcription Factors; Treatment Outcome

2002
Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer.
    International journal of radiation oncology, biology, physics, 2006, Feb-01, Volume: 64, Issue:2

    Topics: Adult; Aged; Biomarkers, Tumor; Carbonic Anhydrases; Cell Hypoxia; Cell Proliferation; Colorectal Neoplasms; Female; Glucose Transporter Type 1; Humans; Idoxuridine; Liver Neoplasms; Male; Middle Aged; Nitroimidazoles

2006
Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers.
    International journal of radiation oncology, biology, physics, 2006, May-01, Volume: 65, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Biomarkers; Carbonic Anhydrases; Cell Hypoxia; Colonic Neoplasms; ErbB Receptors; Female; Humans; Idoxuridine; Male; Microcirculation; Middle Aged; Nitroimidazoles; Observer Variation; Rectal Neoplasms; Vascular Endothelial Growth Factor A

2006
Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas.
    Oral oncology, 2008, Volume: 44, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Proliferation; Female; Head and Neck Neoplasms; Humans; Idoxuridine; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Nitroimidazoles; Nucleic Acid Synthesis Inhibitors; Radiation-Sensitizing Agents; Treatment Outcome

2008